IP Verse

Modulation Of Apolipoprotein C-Iii (Apociii) Expression In Lipoprotein Lipase Deficient (Lpld) Populations

PatentPatent Analysis

EP3400947

IONIS PHARMACEUTICALS
Application Number
EP18179911A
Filing Date
Feb 14, 2014
Status
Granted And Under Opposition
Jul 21, 2023
Grant Date
Aug 23, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3770258B1
EP2906696B2
EP3461895B1

Bibliography

The patent EP3400947B1 was granted to Ionis Pharmaceuticals on Aug 23, 2023 following the initial filing on Feb 14, 2014 under the application number EP18179911A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

AMMELBURGMay 22, 2024ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents